ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Receptor status, molecular subtypes, and survival outcomes of breast cancer following gastric cancer compared with single primary breast cancer.
Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveBreast cancer is a common second primary malignancy among gastric cancer survivors, yet its biological characteristics and clinical outcomes in this population are not well defined. This study aimed to compare molecular features and survival outcomes between breast cancer developing after gastric cancer and single primary breast cancer, and to clarify whether adverse prognosis is related to tumor biology or patient-related factors. MATERIALS AND
methodsThis retrospective population-based study was conducted using the SEER database. Female patients with breast cancer following gastric cancer were compared with those diagnosed with single primary invasive breast cancer. Molecular subtypes, receptor status, clinicopathologic characteristics, and treatment variables were analyzed. Multivariable logistic regression was used to assess associations with molecular features. Overall survival (OS) and breast cancer-specific survival (CSS) were evaluated using Kaplan-Meier analysis and multivariable Cox regression models.
resultsAmong 593,811 included patients, 266 developed breast cancer after gastric cancer. No significant differences were observed between groups in estrogen receptor, progesterone receptor, HER2 status, or molecular subtype distribution. Prior gastric cancer was not independently associated with breast cancer molecular characteristics. Overall survival was significantly worse in patients with a history of gastric cancer (HR, 1.64), whereas breast cancer-specific survival was comparable between groups. Patients with prior gastric cancer were less likely to receive chemotherapy and radiotherapy.
conclusionBreast cancer developing after gastric cancer shows molecular characteristics similar to primary breast cancer. Inferior overall survival appears to be driven by patient-related factors, such as age, comorbidities, and differences in treatment intensity, rather than tumor biology. Preserved CSS indicates comparable responsiveness to standard treatments and underscores the need to avoid unnecessary undertreatment in this patient population.
Indexed as
Identifiers
42151664What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.